Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors
2008 · Bioorganic & Medicinal Chemistry Letters · 83 citations
https://doi.org/10.1016/j.bmcl.2008.12.011
S
Scott H. Dickerson
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
3.4K
Citations
23
h-index
29
i10-index
Scott H. Dickerson is an academic researcher. The author has contributed to research in topics: Melanoma and MAPK Pathways & HER2/EGFR in Cancer Research & Synthesis and biological activity. The author has an h-index of 23, co-authored 34 publications.
Papers by this author
worksSynthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors
2009 · Bioorganic & Medicinal Chemistry Letters · 40 citations
https://doi.org/10.1016/j.bmcl.2009.01.080
Alkynyl pyrimidines as dual EGFR/ErbB2 kinase inhibitors
2006 · Bioorganic & Medicinal Chemistry Letters · 24 citations
https://doi.org/10.1016/j.bmcl.2006.01.111
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors
2008 · Bioorganic & Medicinal Chemistry Letters · 20 citations
https://doi.org/10.1016/j.bmcl.2008.11.023
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat